Clinical investigation of medicinal products for the treatment of sepsis

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/4713/2003
Effective from30/11/2006
KeywordsSepsis, superiority trials, endpoints, inclusion criteria, exclusion criteria, special populations, safety evaluation
DescriptionThis document provides guidance on the clinical development of new medicinal products in the treatment of patients with sepsis.

Related content

How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings

Tell us more